NCT05328479已完成不适用
The Study of Treatment Outcome and Immunogenicity of mild-to Moderate COVID-19 Patients During the Delta vs. the Omicron Pandemic
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5,181
- 试验地点
- 1
- 主要终点
- Anti-SARS-CoV-2 RBD IgG
研究概览
简要总结
The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.
详细描述
The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups 12-18 years, 18-45 years and over 45 years to monitor the symptoms of coronavirus patients treated in home isolation and long-term symptoms including factors related to the patient's recovery in the past, present, and future.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •patient with infected with the novel coronavirus disease 2019 (COVID-19) who has been end of self-quarantine at Siriraj Hospital more than 21 days.
- •Thai nationality, able to read and write Thai language
- •able to use telephone and line to communicate
排除标准
- •people who received additional vaccination after leaving quarantine before the day of the immunization test
结局指标
主要结局
Anti-SARS-CoV-2 RBD IgG
时间窗: Baseline
Anti-RBD IgG (BAU/mL)
Cycle threshold of the first PCR test
时间窗: Baseline
Cycle threshold (Ct)
Anti-SARS-CoV-2 NP
时间窗: Baseline
Anti-SARS-CoV-2 NP (PRNT50 titer)
次要结局
- Number of vaccine injection(Baseline)
- Type of vaccine injection(Baseline)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
EVALUATION OF DIFFERENT PROPHYLACTIC INTERVENTIONS TOWARD COVID-19 IN SOLID ORGAN TRANSPLANT PATIENTSCOVID-19 PandemicTransplant-Related DisorderNCT05629923University of Rome Tor Vergata306
招募中
不适用
Immune response and therapy assessment to COVID-19 Vaccinations in people with Diabetes Mellitus – an observational pilot studyE10E11Type 2 diabetes mellitusType 1 diabetes mellitusDRKS00024879Division Exercise Physiology and Metabolism60
Unknown
4 期
Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.COVID-19NCT05157178The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)1,264
已完成
2 期
GM-CSF as Adjuvant Therapy of MelanomaMalignant MelanomaNCT00350597Northern California Melanoma Center50
招募中
不适用
Study protocol for the HARMONY studyKCT0005173Korea Institute of Oriental Medicine200